Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

[Study of using an individualized treatment strategy to treat patients with chronic hepatitis C].

Nan YM, Zheng HW, Sun DX, An CM, Li YS, Kong L, Dai EH, Zhang YG, Zhao SX, Su SS, Jia YH.

Zhonghua Gan Zang Bing Za Zhi. 2013 Jan;21(1):23-6. doi: 10.3760/cma.j.issn.1007-3418.2013.01.008. Chinese.

PMID:
23663758
2.

[The effects of individualized therapeutic programs on chronic hepatitis C and the influential factors of virological response].

Cheng ML, Wang J, Zeng AP, Liu XF.

Zhonghua Nei Ke Za Zhi. 2012 Oct;51(10):751-4. Chinese.

PMID:
23290969
3.

[Analysis of thyroid dysfunction and influencing factors in chronic hepatitis C patients treated with peg-IFNa-2a and ribavirin].

Huang YX, Chen XY, Ma LN, Yin JM, Ren S, Guo DD, Zheng YH.

Zhonghua Gan Zang Bing Za Zhi. 2012 Mar;20(3):216-20. doi: 10.3760/cma.j.issn.1007-3418.2012.03.016. Chinese.

PMID:
22475143
4.

Individualized treatment strategies and predictors of virological response for chronic hepatitis C: a multicenter prospective study from China.

Nan YM, Zhang YG, Zheng HW, An CM, Li YS, Zhang Y, Sun DX, Li CY, Li Q, Tong LX, Kong LB, Zhao SX, Wang RQ, Meng P, Su SS, He H, Niu XM.

Int J Clin Exp Med. 2015 Sep 15;8(9):14871-84. eCollection 2015.

5.

[Long-term assessment of relapse and associated risk factors in chronic hepatitis C patients treated with interferon and ribavirin].

Li QR, Zhang CJ, Xiong YL, Zhu Y, Tan ZX, Hu YJ, Yuan J, Wang XH.

Zhonghua Gan Zang Bing Za Zhi. 2012 May;20(5):353-6. doi: 10.3760/cma.j.issn.1007-3418.2012.05.010. Chinese.

PMID:
22971280
6.

Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotypes 2a and 2b and high viral load.

Kim SR, El-Shamy A, Imoto S, Kim KI, Sugimoto K, Kim SK, Tanaka Y, Hatae T, Hasegawa Y, Fujinami A, Ohta M, Hotta H, Kudo M.

Dig Dis. 2013;31(5-6):426-33. doi: 10.1159/000355381. Epub 2013 Nov 21.

PMID:
24281016

Supplemental Content

Support Center